Nanoparticles are being tested as potential drug delivery devices for a number of different treatments, but recent research from scientists at the Norwegian Radium Hospital shows that they may, in some cases, hinder cellular function, reports Forbes' Alex Knapp.
...and receive Daily News bulletins.
Already have an account?Login Now.
Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.
Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.
In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.
Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.